iShares Genomics Immunology and Healthcare ETF (IDNA)
- Expense ratio0.47%
- Net assets$321.3M
- Dividend yield0.66%
- 1-year return+66.09%
- Holdings47
IDNA ETF price chart
IDNA quote & trading statistics
IDNA performance
Annual returns & drawdowns →- YTD+59.32%
- 1 year+66.09%
- 3 years+33.76%/yr
- 5 years-2.86%/yr
- 10 years0.00%/yr
- 1Y volatility
- 28.92%
- 3Y volatility
- 25.84%
- 3Y Sharpe ratio
- 0.97
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
IDNA top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | MRNA | Moderna Inc | 11.62% |
| 2 | TWST | Twist Bioscience Corp | 5.52% |
| 3 | IOVA | Iovance Biotherapeutics Inc | 4.72% |
| 4 | GMAB | Genmab A/S | 4.44% |
| 5 | 4502 | Takeda Pharmaceutical Co. Ltd. | 3.89% |
| 6 | REGN | Regeneron Pharmaceuticals Inc | 3.68% |
| 7 | EXEL | Exelixis Inc | 3.64% |
| 8 | RVMD | Revolution Medicines Inc | 3.62% |
| 9 | MRK | Merck & Company Inc | 3.52% |
| 10 | CAI | Caris Life Sciences, Inc. Common Stock | 3.38% |
The top 10 holdings make up 48.0% of the fund (47 holdings in total). As of October 25, 2026.
About iShares Genomics Immunology and Healthcare ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
IDNA ETF FAQ
What is the IDNA expense ratio?
iShares Genomics Immunology and Healthcare ETF has a net expense ratio of 0.47%, or $47.00 a year for every $10,000 invested.
How much money is in IDNA?
iShares Genomics Immunology and Healthcare ETF has about $321.3M in net assets.
What are the top holdings of IDNA?
The largest positions in IDNA are Moderna Inc (11.62%), Twist Bioscience Corp (5.52%), Iovance Biotherapeutics Inc (4.72%). The fund holds 47 securities in total.
How has IDNA performed?
IDNA returned +66.09% over the past year and -2.86% a year over the past five years, including reinvested distributions.
Does IDNA pay dividends?
IDNA has a dividend yield of 0.66%.
When was IDNA launched?
iShares Genomics Immunology and Healthcare ETF began trading on June 11, 2019.